These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 36042173)

  • 1. Genome Editing in Translational Medicine: An Inventory.
    Dobner J; Ramachandran H; Rossi A
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):241. PubMed ID: 36042173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
    Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
    J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing and CRISPR in the clinic: current and future perspectives.
    Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
    Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
    Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
    Guha TK; Edgell DR
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and Evaluation of Zinc Finger Nucleases.
    Ochiai H; Yamamoto T
    Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic editing of hepatocyte genome in vivo.
    Ruiz de Galarreta M; Lujambio A
    J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas systems: Challenges and future prospects.
    Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
    Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genome-editing: focus on the off-target effects].
    He X; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1757-1775. PubMed ID: 29082723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Application of Genome Editing Technologies in Viral Diseases.
    Kim TH; Lee SW
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editing the genome of common cereals (Rice and Wheat): techniques, applications, and industrial aspects.
    Das N; Ghosh Dhar D; Dhar P
    Mol Biol Rep; 2023 Jan; 50(1):739-747. PubMed ID: 36309609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies.
    Nguyen Q; Lim KRQ; Yokota T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals.
    Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM
    Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A history of genome editing in mammals.
    Fernández A; Josa S; Montoliu L
    Mamm Genome; 2017 Aug; 28(7-8):237-246. PubMed ID: 28589393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerns regarding 'off-target' activity of genome editing endonucleases.
    Kadam US; Shelake RM; Chavhan RL; Suprasanna P
    Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
    Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
    Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.